gastrointestinal health
The New York-based company will use the investment to grow its partnerships and coverage among payers and move into Medicare populations in 2025.
The gastrointestinal surgery-focused company will use the funds to advance its endoluminal robotics technology for minimally invasive procedures.
The company's personalized care plans will be available to UHC customers, including its self-funded employers.
The company offers personalized care plans and connects patients with a coordinated care team, including dietitians, internists and gastroenterologists.
The company will use the funds to expand its clinical team nationwide and build relationships with healthcare stakeholders.
Aetna said it would begin offering Oshi's virtual gastrointestinal care in six states, with plans to expand this year.
The company offers a virtual clinic for people with chronic gut conditions like irritable bowel syndrome and gastroesophageal reflux disease.
The company has also launched a distribution unit in the United States.
The company announced a deal with Indegene to launch Regulora, its recently FDA-approved prescription digital therapeutic for treating abdominal pain associated with IBS.
Gastrointestinal-care startup Oshi Health raised $23 million in Series A financing last year.